The driver oncogene in ARMS is the product of a chromosomal translocation that results most commonly in the fusion oncoprotein PAX3-FOXO1, and less frequently PAX7-FOXO1 [4,5,6]. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.